ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e001020
Publisher
BMJ
Online
2020-07-16
DOI
10.1136/jitc-2020-001020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
- (2020) Hao Xu et al. International Journal of Oral Science
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Treating Leukemia in the Time of COVID-19
- (2020) Shilpa Paul et al. ACTA HAEMATOLOGICA
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
- (2020) Jennifer Lighter et al. CLINICAL INFECTIOUS DISEASES
- Diabetes is a risk factor for the progression and prognosis of COVID-19
- (2020) Weina Guo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- COVID-19 in persons with haematological cancers
- (2020) Wenjuan He et al. LEUKEMIA
- Construction of a human cell landscape at single-cell level
- (2020) Xiaoping Han et al. NATURE
- Microbiome analyses of blood and tissues suggest cancer diagnostic approach
- (2020) Gregory D. Poore et al. NATURE
- High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation
- (2020) Arthur Simonnet et al. Obesity
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
- (2020) Jia Luo et al. Cancer Discovery
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
- (2020) Paolo Antonio Ascierto et al. Journal for ImmunoTherapy of Cancer
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- The Immune Landscape of Cancer
- (2019) Vésteinn Thorsson et al. IMMUNITY
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
- (2018) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
- (2016) Stefani Spranger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
- (2015) Hin Chu et al. JOURNAL OF INFECTIOUS DISEASES
- The intestinal microbiota and susceptibility to infection in immunocompromised patients
- (2013) Ying Taur et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Immunity to viruses
- (2013) Thomas J. Braciale et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More